Compare ALEMBIC PHARMA with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA PFIZER ALEMBIC PHARMA/
PFIZER
 
P/E (TTM) x 16.4 44.2 37.1% View Chart
P/BV x 6.5 7.3 89.2% View Chart
Dividend Yield % 0.6 0.5 125.1%  

Financials

 ALEMBIC PHARMA   PFIZER
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
PFIZER
Mar-19
ALEMBIC PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs6643,840 17.3%   
Low Rs4122,080 19.8%   
Sales per share (Unadj.) Rs208.7455.0 45.9%  
Earnings per share (Unadj.) Rs31.093.8 33.1%  
Cash flow per share (Unadj.) Rs37.1109.4 33.9%  
Dividends per share (Unadj.) Rs5.5022.50 24.4%  
Dividend yield (eoy) %1.00.8 134.4%  
Book value per share (Unadj.) Rs144.2658.2 21.9%  
Shares outstanding (eoy) m188.5245.75 412.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.66.5 39.6%   
Avg P/E ratio x17.431.6 55.0%  
P/CF ratio (eoy) x14.527.1 53.6%  
Price / Book Value ratio x3.74.5 83.0%  
Dividend payout %17.724.0 74.0%   
Avg Mkt Cap Rs m101,461135,420 74.9%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m7,4673,238 230.6%   
Avg. sales/employee Rs ThNM7,911.4-  
Avg. wages/employee Rs ThNM1,230.9-  
Avg. net profit/employee Rs ThNM1,630.7-  
INCOME DATA
Net Sales Rs m39,34720,815 189.0%  
Other income Rs m941,674 5.6%   
Total revenues Rs m39,44122,489 175.4%   
Gross profit Rs m8,7365,712 152.9%  
Depreciation Rs m1,152714 161.4%   
Interest Rs m18473 252.5%   
Profit before tax Rs m7,4936,599 113.5%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5682,309 67.9%   
Profit after tax Rs m5,8444,291 136.2%  
Gross profit margin %22.227.4 80.9%  
Effective tax rate %20.935.0 59.8%   
Net profit margin %14.920.6 72.1%  
BALANCE SHEET DATA
Current assets Rs m19,57727,167 72.1%   
Current liabilities Rs m14,8968,917 167.1%   
Net working cap to sales %11.987.7 13.6%  
Current ratio x1.33.0 43.1%  
Inventory Days Days9068 132.3%  
Debtors Days Days4530 150.7%  
Net fixed assets Rs m27,0978,862 305.8%   
Share capital Rs m377458 82.4%   
"Free" reserves Rs m26,81129,656 90.4%   
Net worth Rs m27,18830,113 90.3%   
Long term debt Rs m4,99325 19,972.0%   
Total assets Rs m47,77839,400 121.3%  
Interest coverage x41.791.5 45.6%   
Debt to equity ratio x0.20 22,120.8%  
Sales to assets ratio x0.80.5 155.9%   
Return on assets %12.611.1 113.9%  
Return on equity %21.514.2 150.9%  
Return on capital %23.622.1 106.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,453428 4,541.8%   
Fx outflow Rs m6,065786 771.2%   
Net fx Rs m13,388-358 -3,738.6%   
CASH FLOW
From Operations Rs m8,120978 830.1%  
From Investments Rs m-7,556351 -2,151.5%  
From Financial Activity Rs m590-1,099 -53.7%  
Net Cashflow Rs m1,153231 499.7%  

Share Holding

Indian Promoters % 74.1 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 2.9 7.5 38.7%  
FIIs % 9.1 4.9 185.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 23.7 58.6%  
Shareholders   49,328 85,207 57.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   TORRENT PHARMA  NATCO PHARMA  ELDER PHARMA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Crucial Week Ahead for the Indian Stock Market(Momentum Moves)

The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jan 22, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS